Showing results (1-10 of 268) with videos related to
Sort By:
Pageof 27
Frontiers in Medicine|October 27, 2022
Current and investigational drugs in early clinical development for portal hypertensionSasan Sakiani, Theo Heller, Christopher KohThe Journal of Infectious Diseases|June 20, 2014
Understanding the presence of false-positive antibodies in acute hepatitisSasan Sakiani, Christopher Koh, Theo HellerClinics in Liver Disease|April 6, 2019
Hepatic Manifestations of Cystic FibrosisSasan Sakiani, David E Kleiner, Theo Heller, et al.Journal of Clinical Microbiology|March 8, 2013
Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated regionKoji Hara, Maria M Rivera, Christopher Koh, et al.Hepatology (Baltimore, Md.)|April 20, 2017
Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entityChristopher Koh, Sasan Sakiani, Pallavi Surana, et al.World Journal of Gastroenterology|September 19, 2019
Chronic hepatitis delta: A state-of-the-art review and new therapiesChristy Gilman, Theo Heller, Christopher KohJournal of Viral Hepatitis|February 5, 2022
Chronic hepatitis D-What is changing?David Yardeni, Theo Heller, Christopher KohGastroenterology Clinics of North America|May 12, 2020
Hepatitis Delta: Prevalence, Natural History, and Treatment OptionsJulian Hercun, Christopher Koh, Theo HellerHepatology (Baltimore, Md.)|June 19, 2013
AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendationsChristopher Koh, Xiongce Zhao, Niharika Samala, et al.Gastroenterology|October 22, 2018
Pathogenesis of and New Therapies for Hepatitis DChristopher Koh, Theo Heller, Jeffrey S GlennPageof 27